Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
42.6M
-
Number of holders
-
49
-
Total 13F shares, excl. options
-
29.5M
-
Shares change
-
-1.12M
-
Total reported value, excl. options
-
$29.1M
-
Value change
-
-$1.27M
-
Number of buys
-
19
-
Number of sells
-
-28
-
Price
-
$0.99
Significant Holders of Repare Therapeutics Inc. - Common Shares (RPTX) as of Q1 2025
64 filings reported holding RPTX - Repare Therapeutics Inc. - Common Shares as of Q1 2025.
Repare Therapeutics Inc. - Common Shares (RPTX) has 49 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29.5M shares
of 42.6M outstanding shares and own 69.35% of the company stock.
Largest 10 shareholders include BVF INC/IL (10.3M shares), Blue Owl Capital Holdings LP (3.44M shares), ORBIMED ADVISORS LLC (3.32M shares), Versant Venture Management, LLC (2.65M shares), Redmile Group, LLC (1.88M shares), Aquilo Capital Management, LLC (1.29M shares), ARK Investment Management LLC (1.12M shares), MPM ASSET MANAGEMENT LLC (1.12M shares), CITADEL ADVISORS LLC (937K shares), and MPM BIOIMPACT LLC (820K shares).
This table shows the top 49 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.